Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Pfizer divestiture

This article was originally published in The Gray Sheet

Executive Summary

Surgical ophthalmology business acquired through Pharmacia in April will be sold, drug firm announces. The unit, which generated roughly $150 mil. in revenue in 2002, manufactures the Healon visco-elastic for ocular surgery, as well as the CeeOn and Tecnic intraocular lenses. Manufacturing facilities are located in Groningen, The Netherlands, and Uppsala, Sweden. Potential bidders likely include ophthalmic device firms Bausch & Lomb and Alcon. Pfizer has said it intends to shed all non-core assets purchased from Pharmacia (1"The Gray Sheet" July 7, 2003, p. 8)...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts